← Open Payments lookup

CINDY CHANG: Open Payments

NPI 1316561236 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,259 in 144 payments from 23 companies in 2025. Trend: 2023 $2,909 · 2024 $2,745 · 2025 $3,259

Food & beverage: $3,259
CompanyPaymentsAmount
ABBVIE INC.34$770
Janssen Biotech, Inc.18$425
Aimmune Therapeutics, Inc.22$349
Takeda Pharmaceuticals U.S.A., Inc.7$258
Ardelyx, Inc.9$246
GENZYME CORPORATION7$236
Madrigal Pharmaceuticals7$185
Ipsen Biopharmaceuticals, Inc6$171
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$149
Gilead Sciences, Inc.6$102

Products named: TREMFYA, LINZESS, DUPIXENT, IBSRELA, ENTYVIO, REZDIFFRA, VOWST, IQIRVO.

Industry payments across AZ — which companies pay providers there.